Katarina Ageborg

Chief Compliance Officer at AstraZeneca Plc

Katarina Ageborg

Katarina Ageborg

Chief Compliance Officer at AstraZeneca Plc

Biography

Currently, Katarina Ageborg occupies the position of Chief Compliance Officer & EVP-Sustainability at AstraZeneca Plc. Ms. Ageborg received a graduate degree from the University of Uppsala.

Overview
RelSci Relationships

606

Relationships
RelSci Relationships are individuals Katarina Ageborg likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Director & Chief Executive Officer at AstraZeneca Plc

Relationship likelihood: Strong

Chief Financial Officer & Executive Director at AstraZeneca Plc

Relationship likelihood: Strong

President, BioPharmaceuticals Business Unit at AstraZeneca LP

Relationship likelihood: Strong

Head, Respiratory Global Medicines, Astrazeneca & Chief Executive Officer of Pearl Therapeutics at AstraZeneca Plc

Relationship likelihood: Strong

Chief Technology Officer & Global Head of Antibody Discovery & Protein Engineering (Adpe), Medimmune at AstraZeneca Plc

Relationship likelihood: Strong

Chief Executive Officer at Brambles Ltd.

Relationship likelihood: Strong

Former President & Chief Executive Officer at Investor AB

Relationship likelihood: Strong

Head of Oncology Strategic Combinations at AstraZeneca Plc

Relationship likelihood: Strong

Senior Director, BioTech Partnering & Strategy at MedImmune LLC

Relationship likelihood: Strong

Director, BioTech Partnering & Strategy & Head, Out-Licensing & Spin Outs at MedImmune LLC

Relationship likelihood: Strong

Paths to Katarina Ageborg
Potential Connections via
Relationship Science
You
Katarina Ageborg
Chief Compliance Officer at AstraZeneca Plc
Education
Graduate

Uppsala Universty is a world class research and educational institution in Sweden.

Career History
Chief Compliance Officer
1998 - Current

AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 4831, azd 8601, medi 6012, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Other Affiliations

Katarina Ageborg is affiliated with AstraZeneca Plc

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Katarina Ageborg. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Katarina Ageborg's profile does not indicate a business or promotional relationship of any kind between RelSci and Katarina Ageborg.